Clinical Trial Update: Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell Centers

View source ↗

Summary

This document reports a preliminary real-world analysis of patient characteristics and treatment patterns among crizanlizumab users in select sickle cell center…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ADAKVEO (crizanlizumab)

Snippet

Sponsor: Novartis | Conditions: Sickle Cell Disease | Status: COMPLETED